The first global mapping of artemisinin resistance (the KARMA study) has definitively confirmed that resistance to the main drug currently used in the treatment of Plasmodium falciparum malaria is for the moment confined ...
Jun 23, 2016
0
1
Cerebral malaria is a serious complication of infection with the malaria parasite, affecting approximately one in a thousand children in areas where malaria is common. Many of the patients die, and among those who survive, ...
Mar 6, 2014
0
0
No new cases of malaria originated in Europe, Central Asia or the Caucasus in 2015, the first year without a transmission for almost 30 years, the World Health Organization said Wednesday.
Apr 20, 2016
0
1
A scientist at the Albert Schweitzer Hospital's medical research unit said Wednesday that trials of a new antimalarial drug were encouraging and paved the way for licensing.
Apr 25, 2012
0
0
Exposure to suboptimal doses of the antiparasitic drug artemisinin could increase the sexual conversion rate of the malaria parasite Plasmodium falciparum, thereby increasing the probability of transmission, according to ...
Oct 28, 2020
0
4
Despite major progress in the global fight to end malaria, the parasite responsible for the disease has evolved resistance to every antimalarial drug deployed to date.
Jul 20, 2021
0
47
A new study shows that patients with rheumatic diseases across Africa, Southeast Asia, the Americas and Europe had trouble filling their prescriptions of antimalarial drugs, including hydroxychloroquine, during the 2020 global ...
Nov 6, 2020
0
2
Limited global supplies may scupper proposals to use the antimalarial drugs, chloroquine and hydroxychloroquine, to lessen the symptoms of Covid-19 infection or ward it off altogether, say Italian doctors in a letter published ...
Apr 2, 2020
0
0
Melbourne researchers are making progress towards new antimalarial drugs, after revealing how an antibiotic called emetine blocks the molecular machinery that produces the proteins required for malaria parasite survival.
Sep 3, 2014
0
0
The treatment of systemic lupus erythematosus has traditionally been based on glucocorticoids administered orally. Nevertheless, these drugs were known to cause serious side effects in the medium to long term. In order to ...
Jun 17, 2014
0
0
